Please login to the form below

Not currently logged in
Email:
Password:

US drug prices

This page shows the latest US drug prices news and features for those working in and with pharma, biotech and healthcare.

Pfizer CEO reckons rebates will disappear, and that’s a positive

Pfizer CEO reckons rebates will disappear, and that’s a positive

Pfizer’s chief executive Ian Read (pictured below) has said that he expects drug price rebates will eventually disappear in the US, and that could give drugs like arthritis drug Xeljanz ... Abandoning rebates could deliver a situation where drug prices

Latest news

More from news
Approximately 2 fully matching, plus 16 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2017 Deal Watch January 2017

    bear on US drug prices and the possible revocation of Obamacare in part, if not in full. ... 230. Cymabay. Kowa. Exclusive licence in the US. Arhalofenate for gout p3 ready.

  • Tracking comms trends: Europe in the global vanguard on value Tracking comms trends: Europe in the global vanguard on value

    But this is changing. President Obama, plus candidates Donald Trump and Hillary Clinton, have all proposed that Medicare should negotiate drug prices. ... More locally, US HMOs and insurance funds are using levels of HTA and deploying cost containment

  • Social media and inflation penalties for generic drugs Social media and inflation penalties for generic drugs

    Social media and inflation penalties for generic drugs. US generic drug companies are under more scrutiny as the US public becomes more vocal . ... In reality, the omission of a similar inflation penalty for generics has allowed drug prices in that

  • The price is right? The price is right?

    Drug pricing is currently taking centre stage in the lead up to the 2016 US Presidential Election. ... Hillary Clinton's pitch to become the Democrat candidate has majored heavily on tackling 'runaway prescription drug prices' - and the intensity of her

  • Country report: The healthcare market in South Korea Country report: The healthcare market in South Korea

    This is a vaguely defined concept; drug prices in the US average more than twice as high as in many other wealthy countries. ... The single insurer aim is to reduce prices by 20 per cent and these cannot exceed those in main markets such as France,

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics